Tomás Rodríguez
Impact in
- Aging top 5%
- Genetics, Aging, and Longevity in Model Organisms
-
- Innovation and Socioeconomic Development
Papers in
-
- CRISPR and Genetic Engineering 6
- RNA and protein synthesis mechanisms 4
- RNA regulation and disease 3
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 2
-
- Hippo pathway signaling and YAP/TAZ 2
- Co-authors
- Erik J. Sontheimer (10 shared papers)Wen Xue (5 shared papers)Zexiang Chen (2 shared papers)Scot A. Wolfe (4 shared papers)Shun‐Qing Liang (2 shared papers)Xin D. Gao (4 shared papers)Bin Liu (1 shared paper)Xiaolong Dong (1 shared paper)
- Journals
- Nature Biotechnology (3 papers)Hepatology (2 papers)Nature Communications (1 paper)Journal of Clinical Microbiology (1 paper)Progress in molecular biology and translational science (1 paper)
- Partner nations
- United StatesGreeceChina
In The Last Decade
Tomás Rodríguez
16 papers receiving 602 citations
Peers
Comparison fields: 5 of 66
- Aging 47
- Business and International Management 42
- Molecular Biology 471
- Endocrinology 27
- Genetics 135
Countries citing papers authored by Tomás Rodríguez
This map shows the geographic impact of Tomás Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás Rodríguez more than expected).
Fields of papers citing papers by Tomás Rodríguez
This network shows the impact of papers produced by Tomás Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás Rodríguez. The network helps show where Tomás Rodríguez may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomás Rodríguez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 130 | |
| 2 | 2018 | 100 | |
| 3 | 2020 | 97 | |
| 4 | 2021 | 84 | |
| 5 | 2022 | 47 | |
| 6 | Pathogen infection and cholesterol deficiency activate the C. elegans p38 immune pathway through a TIR-1/SARM1 phase transition | 2022 | 40 |
| 7 | 2004 | 37 | |
| 8 | 2020 | 18 | |
| 9 | 2021 | 18 | |
| 10 | 2022 | 15 | |
| 11 | 2021 | 12 | |
| 12 | 2018 | 3 | |
| 13 | 2020 | 3 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2015 | 0 |
About Tomás Rodríguez
Tomás Rodríguez is a scholar working on Molecular Biology, Cell Biology, Pathology and Forensic Medicine, Oncology and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 608 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (6 papers), RNA and protein synthesis mechanisms (4 papers), RNA regulation and disease (3 papers), RNA Interference and Gene Delivery (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Virus-based gene therapy research (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). The work is most often cited by research in Aging (47 citations), Business and International Management (42 citations), Molecular Biology (471 citations), Endocrinology (27 citations) and Genetics (135 citations). Tomás Rodríguez has collaborated with scholars based in United States, Greece and China. Frequent co-authors include Erik J. Sontheimer, Wen Xue, Zexiang Chen, Scot A. Wolfe, Shun‐Qing Liang, Xin D. Gao, Bin Liu, Xiaolong Dong, Chunwei Zheng and Aamir Mir. Their work appears in journals such as Nature Biotechnology, Hepatology, Nature Communications, Journal of Clinical Microbiology and Progress in molecular biology and translational science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.